# FDA recall D-0077-2018

> **Allergan Sales, LLC** · Class III · drug recall initiated 2017-10-19.

## Product

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612..

## Reason for recall

Failed Impurities/Degradation Specifications.

## Distribution

Nationwide and  Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.

## Key facts

- **Recall number:** D-0077-2018
- **Recalling firm:** Allergan Sales, LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-10-19
- **Report date:** 2017-11-22
- **Termination date:** 2019-10-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Waco, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0077-2018

## Citation

> AI Analytics. FDA recall D-0077-2018. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-0077-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*